{
    "clinical_study": {
        "@rank": "121116", 
        "acronym": "NEAT", 
        "arm_group": {
            "arm_group_label": "EndoAVF", 
            "arm_group_type": "Experimental", 
            "description": "The FLEX System will be used to percutaneously  create a fistula in CKD patients who require hemodialysis vascular access"
        }, 
        "brief_summary": {
            "textblock": "The objective of this study is to characterize the safety and efficacy of the FLEX System\n      when used to create an arteriovenous fistula (AVF or AV fistula) percutaneously in patients\n      with Chronic Kidney Disease (CKD) who require hemodialysis vascular access."
        }, 
        "brief_title": "Novel Endovascular Access Trial (NEAT)", 
        "completion_date": {
            "#text": "June 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Chronic Kidney Disease", 
        "condition_browse": {
            "mesh_term": [
                "Kidney Diseases", 
                "Renal Insufficiency, Chronic", 
                "Kidney Failure, Chronic"
            ]
        }, 
        "detailed_description": {
            "textblock": "This is a 12 month multi-center non-randomized open label investigational study to\n      characterize the safety and efficacy of the FLEX system to create an endovascular AVF in\n      patients with CKD who require hemodialysis vascular access."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Eligible for a native surgical arteriovenous fistula, as determined by the treating\n             physician.\n\n          -  Adult (age >18 years old).\n\n          -  Established, non-reversible kidney failure requiring hemodialysis.\n\n          -  Written informed consent obtained.\n\n        Exclusion Criteria:\n\n          -  Functioning surgical access in the planned treatment arm.\n\n          -  Pregnant women.\n\n          -  New York Heart Association (NYHA) class III or IV heart failure.\n\n          -  Allergy to contrast dye."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "70", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 10, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02036671", 
            "org_study_id": "VAP-0001"
        }, 
        "intervention": {
            "arm_group_label": "EndoAVF", 
            "intervention_name": "The FLEX System will be used to percutaneously  create a fistula in CKD patients who require hemodialysis vascular access", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Arteriovenous fistula", 
            "Fistula", 
            "Chronic kidney disease", 
            "Percutaneous", 
            "Kidney Disease", 
            "Kidney Failure, Chronic", 
            "Urologic Diseases", 
            "Renal Insufficiency, Chronic", 
            "Renal Insufficiency", 
            "CKD", 
            "hemodialysis"
        ], 
        "lastchanged_date": "January 13, 2014", 
        "location": [
            {
                "contact": {
                    "email": "mkiaii@providencehealth.bc.ca", 
                    "last_name": "Mercedeh Kiaii, MD, FRCP(C)", 
                    "phone": "604-681-7191"
                }, 
                "facility": {
                    "address": {
                        "city": "Vancouver", 
                        "country": "Canada", 
                        "state": "British Columbia", 
                        "zip": "V6Z 1Y6"
                    }, 
                    "name": "St. Paul's Hospital"
                }, 
                "investigator": {
                    "last_name": "Mercedeh Kiaii, MD, FRCP(C)", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "charmaine.lok@uhn.ca", 
                    "last_name": "Charmaine Lok, MD", 
                    "phone": "416-340-4140"
                }, 
                "facility": {
                    "address": {
                        "city": "Toronto", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "M5G 2C4"
                    }, 
                    "name": "The Toronto General Hospital"
                }, 
                "investigator": {
                    "last_name": "Charmaine Lok, MD, MSC, FRCPC", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "1", 
        "official_title": "Novel Endovascular Access Trial (NEAT): A Study of the FLEX System for Percutaneous AV Fistula Creation in Hemodialysis Patients", 
        "overall_contact": {
            "email": "laurie.lynch@visi.com", 
            "last_name": "Laurie E Lynch, PhD", 
            "phone": "952-221-2468"
        }, 
        "overall_official": {
            "affiliation": "The Toronto General Hospital", 
            "last_name": "Charmaine Lok, MD, MSC, FRCPC", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: Health Canada", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "The number of participants who experience device or procedure-related adverse events", 
            "safety_issue": "Yes", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02036671"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Functional Fistula (Efficacy): The percentage of AV fistulas that can provide prescribed hemodialysis over a 4 consecutive week period.", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "source": "TVA Medical Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "TVA Medical Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}